Paper Details

  1. Home
  2. Paper Details

Lacosamide in trigeminal neuralgia: report of a case refractory to first- and second-generation anticonvulsants.

Author: AdamoDaniela, CoppolaNoemi, MignognaMichele Davide, NicolòMichele, PecoraroGiuseppe

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Trigeminal neuralgia (TN) is often treated with anticonvulsants, but side effects can be a problem, particularly in older patients. Lacosamide, a newer anticonvulsant, has fewer side effects and shows promise for treating neuropathic pain associated with TN.
Paper Details　
Original Abstract of the Article :
The treatment of trigeminal neuralgia (TN) involves first- and second-generation anticonvulsants. However, side effects (SEs) impair compliance with treatment, especially in elderly patients. Lacosamide (LCM) is a third-generation anticonvulsant with a mechanism of action that is not completely clea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/08869634.2020.1804233

データ提供：米国国立医学図書館（NLM）

Lacosamide in Trigeminal Neuralgia: Report of a Case Refractory to First- and Second-Generation Anticonvulsants

Trigeminal neuralgia, a condition characterized by severe pain in the face, is like a searing desert wind that can cause agonizing pain. This research explores the use of lacosamide (LCM), a third-generation anticonvulsant, in treating trigeminal neuralgia in a patient who did not respond to traditional treatments.

Lacosamide: A Potential Treatment for Trigeminal Neuralgia

The study describes the successful use of LCM in a patient with trigeminal neuralgia who did not respond to first- and second-generation anticonvulsants. This is like finding a new oasis in the desert, offering a source of relief for someone suffering from excruciating pain. The research suggests that LCM could be a valuable treatment option for patients with refractory trigeminal neuralgia.

Treating Trigeminal Neuralgia

This study provides hope for patients with trigeminal neuralgia who have not found relief from traditional treatments. It's a reminder that even in the face of persistent pain, there may be new and effective treatment options available.

Dr.Camel's Conclusion

This case report highlights the potential of LCM for treating trigeminal neuralgia. It's like discovering a hidden spring in the desert, offering a source of relief from the searing pain. While more research is needed to fully understand LCM's effectiveness, this study suggests that it could be a valuable option for patients who have not found relief from traditional treatments. It's a reminder that even in the most desolate of deserts, there are opportunities for hope and healing.
Date :
  1. Date Completed 2023-04-24
  2. Date Revised 2023-04-24
Further Info :

Pubmed ID

32776864

DOI: Digital Object Identifier

10.1080/08869634.2020.1804233

Related Literature

Article Analysis
・Side Effects of lacosamide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.